Download PDF
CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2020; 11(03): 187-192
DOI: 10.1055/s-0040-1716447
Research Article

Use of n-Butyl 2 Cyanoacrylate without Lipiodol, Using a Modified Protocol in Gastric Variceal Bleed Management: Retrospective Analysis of 2299 Patients

Pankaj N. Desai
1   Department of Endoscopy & Endosonography, Surat Institute of Digestive Sciences (SIDS), Surat, India
,
Chintan N. Patel
1   Department of Endoscopy & Endosonography, Surat Institute of Digestive Sciences (SIDS), Surat, India
,
Mayank V. Kabrawala
1   Department of Endoscopy & Endosonography, Surat Institute of Digestive Sciences (SIDS), Surat, India
,
Rajiv M. Mehta
2   Department of Gastroenterology, Surat Institute of Digestive Sciences (SIDS), Surat, India
,
Subhash K. Nandwani
2   Department of Gastroenterology, Surat Institute of Digestive Sciences (SIDS), Surat, India
,
Ritesh Prajapati
2   Department of Gastroenterology, Surat Institute of Digestive Sciences (SIDS), Surat, India
,
Nisharg Patel
2   Department of Gastroenterology, Surat Institute of Digestive Sciences (SIDS), Surat, India
,
Krishna K. Parekh
3   Department of Clinical Research, Surat Institute of Digestive Sciences (SIDS), Surat, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Aim To assess the feasibility and amount of cyanoacrylate glue that can be injected safely per session, complications, and long-term results in GOV1, GOV2 and IGV1 varices, using a modified method.

Method All patients from October 2008 to December 2019 presenting to us with variceal bleeding were included. We injected 0.5 mL of cyanoacrylate glue followed by 1.5 mL to 3 mL distilled water in all GOV 1, GOV 2 and IGV varices. Number of glues used were not restricted. Esophageal variceal ligation (EVL) was done for esophageal varices. Follow-up was done at 4 weeks and 3 to 6 months and analyzed.

Results 2299 patients received therapy. Male:female, 69%:31%. Causes of varices–cirrhosis (84.9%) and extrahepatic portal vein obstruction (EHPVO) (15.1%). Causes of cirrhosis–alcohol (38.4%), nonalcoholic fatty liver disease (NAFLD) (29%), hepatitis B (19.9%), hepatitis C (10.1%), Wilson’s disease (1.8%), and autoimmune diseases (0.9%). As much as 41.1% had blood in stomach and 10.2% had active spurt on index endoscopy. As much as 14.5% required endotracheal intubation (active bleed [53.1%], encephalopathy [40.5%], respiratory distress [6.6%]). As much as 30.9% had GOV1 + GOV2, 1.5% had GOV2 + IGV1, 21.3% had GOV1 + IGV1 and 16.4% had GOV1 + GOV2 + IGV1. Hemostasis could be achieved in 99.2% on index endoscopy. A total of 18 (0.8%) patients had uncontrolled bleed of whom 10 (55.6%) had hepatocellular carcinoma. Ongoing bleed was treated with transjugular intrahepatic portosystemic shunt (TIPSS) (61.1%) and endoscopic ultrasound (EUS)-guided coiling (38.8%). Amount of glue required for gastric variceal obturation was 3.6 on index endoscopy, 1.6 on follow-up at 4 to 6 weeks, and 1.2 at 3 months follow up. Glue extrusion with ulcers were seen in 6.4% at 4 to 6 weeks and 4.3% at 3 months. Rebleed occurred in 2.1% and 0.7% patients before 4 weeks and 3 months follow-up, respectively. As much as 1.3% and 1.2% patients were lost to follow-up before 4 weeks and 3 months follow-up sessions, respectively. Complications include pulmonary aspiration in 0.9% and bleeding from ulcers 2.8%. No evidence of pulmonary embolism was seen. In two endoscopic procedures, glue splashing into operator’s eyes occurred. Incidents of needle getting stuck in the varix occurred in three patients.

Conclusions Our modified protocol for glue in gastric varices is safe and feasible, as it has less rebleed, no pulmonary embolism and less ulcers with glue extrusion as compared with available literature.

Keywords

cyanoacrylate glue - gastric varices - variceal bleed


Publication History

Article published online:
28 August 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Kumar A, Singh S, Madan K, Garg PK, Acharya SK. Undiluted N-butyl cyanoacrylate is safe and effective for gastric variceal bleeding. Gastrointest Endosc 2010; 72 (04) 721-727
    CrossrefPubMedGoogle Scholar
  • 2 Cheng L-F, Wang Z-Q, Li C-Z, Lin W, Yeo AET, Jin B. Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol 2010; 8 (09) 760-766
    CrossrefPubMedGoogle Scholar
  • 3 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017; 65 (01) 310-335
    CrossrefPubMedGoogle Scholar
  • 4 Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002; 97 (04) 1010-1015
    CrossrefPubMedGoogle Scholar
  • 5 Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995; 27 (05) 349-354
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33 (05) 1060-1064
    CrossrefPubMedGoogle Scholar
  • 7 Procaccini NJ, Al-Osaimi AMS, Northup P. Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 2009; 70 (05) 881-887
    CrossrefPubMedGoogle Scholar
  • 8 Tan P-C, Hou M-C, Lin H-C. et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 2006; 43 (04) 690-697
    CrossrefPubMedGoogle Scholar
  • 9 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (06) 1343-1349
    CrossrefPubMedGoogle Scholar
  • 10 Saraswat VA, Verma A. Gluing gastric varices in 2012: lessons learnt over 25 years. J Clin Exp Hepatol 2012; 2 (01) 55-69
    CrossrefPubMedGoogle Scholar
  • 11 Gotlib J-P. Endoscopic obturation of esophageal and gastric varices with a cyanoacrylic tissue adhesive. Can J Gastroenterol 1990; 4: 637-638
    CrossrefGoogle Scholar
  • 12 Wang Y-M, Cheng L-F, Li N, Wu K, Zhai J-S, Wang Y-W. Study of glue extrusion after endoscopic N-butyl-2-cyanoacrylate injection on gastric variceal bleeding. World J Gastroenterol 2009; 15 (39) 4945-4951
    CrossrefPubMedGoogle Scholar
  • 13 Seewald S, Ang TL, Imazu H. et al. A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointest Endosc 2008; 68 (03) 447-454
    CrossrefPubMedGoogle Scholar
  • 14 Seewald S, Sriram PVJ, Naga M. et al. Cyanoacrylate glue in gastric variceal bleeding. Endoscopy 2002; 34 (11) 926-932
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Ríos Castellanos E, Seron P, Gisbert JP, Bonfill Cosp X. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension. Cochrane Database Syst Rev 2015; (05) CD010180
    PubMedGoogle Scholar
  • 16 Kind R, Guglielmi A, Rodella L. et al. Bucrylate treatment of bleeding gastric varices: 12 years’ experience. Endoscopy 2000; 32 (07) 512-519
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Lee HA, Chang JM, Goh HG. et al. Korean Portal Hypertension Study Group. Prognosis of patients with gastric variceal bleeding after endoscopic variceal obturation according to the type of varices. Eur J Gastroenterol Hepatol 2019; 31 (02) 211-217
    CrossrefPubMedGoogle Scholar